Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03233555 · ClinicalTrials.gov registry record · NA

Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer

A NA study, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
535
Enrollment target

NCT03233555 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 535 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03233555, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
535 participants
Enrollment target

Study Summary

This study tests four different methods of educating patients about follow-up care (NCI facing forward, brochure, EXCELS website alone, EXCELS health coaching alone and EXCELS website \& health coaching combination) after cancer treatment ends. While it is known that patients need information to guide follow-up it remains unknown how to best provide this in primary care.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • OTHER Internet-Based Intervention
  • OTHER Informational Intervention
  • BEHAVIORAL Telephone-Based Intervention

Trial Details

FieldValue
Enrollment Target 535 participants
Start Date 2013-09-03
Est. Completion 2022-07-31
Phase NA

What the Registry Record Tells You About NCT03233555

The ClinicalTrials.gov registry entry for NCT03233555 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 535 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.

NCT03233555 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03233555 about?

NCT03233555 is a clinical study titled "Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer". This study tests four different methods of educating patients about follow-up care (NCI facing forward, brochure, EXCELS website alone, EXCELS health coaching alone and EXCELS website \& health coaching combination) after cancer treatment ends. While it is known that patients need information to gui...

What is the current status of trial NCT03233555?

This trial is currently completed. It is a NA study. The enrollment target is 535 participants. The study started on 2013-09-03. Estimated completion is 2022-07-31.

What interventions are being tested in trial NCT03233555?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Internet-Based Intervention (OTHER), Informational Intervention (OTHER), Telephone-Based Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03233555?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.